Study of IMC-1121B in Patients With Advanced Solid Tumors
Clinical trial NCT01005355 · COMPLETED
Trial details
- NCT number
- NCT01005355
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-02-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.